On January 20, 2025, United States President Donald Trump signed Executive Order 14155, titled “Withdrawing the United States from the World Health Organization”. This executive order directs the withdrawal of the United States from the World Health Organization (WHO), marking a significant shift in the country’s approach to global health governance. The move is not without precedent, as it marks the second time the United States has ordered its withdrawal from the WHO.
The World Health Organization is a specialized agency of the United Nations responsible for international public health. The United States has been a member of the WHO since its inception and has played a significant role in shaping the organization’s policies and programs. However, the Trump administration has expressed concerns about the WHO’s effectiveness and has sought to reevaluate the country’s relationship with the organization.
Executive Order 14155 is a significant development in the United States’ approach to global health governance. The order reflects the Trump administration’s desire to reassert its independence and sovereignty in international affairs. By withdrawing from the WHO, the United States is seeking to distance itself from an organization that it perceives as ineffective and inefficient. The move is likely to have significant implications for global health governance and may lead to a reevaluation of the WHO’s role and functions.
The withdrawal from the WHO is also likely to have significant implications for the United States’ own global health initiatives. The WHO has played a critical role in supporting global disease surveillance systems, and the United States has been a major contributor to these efforts. The Trump administration has proposed alternative arrangements for global disease surveillance, but it remains to be seen how these will be implemented and funded. The administration has proposed spending $2 billion per year to duplicate the kinds of global disease surveillance systems that it helped build and accessed at a fraction of the cost through its WHO membership.
The decision to withdraw from the WHO has been the subject of much debate and discussion. While some have welcomed the move as a necessary step towards reasserting American sovereignty, others have expressed concerns about the potential consequences for global health governance. The WHO has played a critical role in supporting global health initiatives, and the loss of American participation may undermine the organization’s effectiveness. As the United States moves forward with its withdrawal, it remains to be seen how the WHO will adapt to the loss of one of its largest and most influential members.
As the situation continues to unfold, it will be important to watch how the United States’ withdrawal from the WHO affects global health governance. The Trump administration’s proposal to spend $2 billion per year on global disease surveillance systems is a significant development, and it remains to be seen how these efforts will be implemented and funded. The WHO’s response to the United States’ withdrawal will also be critical, as the organization seeks to adapt to the loss of one of its largest and most influential members. As the global health community moves forward, it will be essential to monitor these developments and assess their implications for global health governance.
Looking ahead, the coming months and years will be critical in determining the impact of the United States’ withdrawal from the WHO. The Trump administration’s plans for global disease surveillance and the WHO’s response to the withdrawal will be closely watched by the global health community. As the situation continues to evolve, it will be essential to stay informed about the latest developments and to assess their implications for global health governance. The United States’ withdrawal from the WHO marks a significant shift in the country’s approach to global health governance, and it remains to be seen how this will play out in the years to come.
